|
|
![]() | ![]() | ![]() | ![]() |
These excerpts taken from the EXAC 10-K filed Mar 13, 2009. RESULTS OF OPERATIONS The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our historical consolidated financial statements and related notes thereto in Item 8. Financial Statements and Supplementary Data. The discussion below contains forward-looking statements that are based upon our current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from these expectations due to inaccurate assumptions and known or unknown risks and uncertainties, including those identified in Cautionary Note Regarding Forward-Looking Statements and Item lA. Risk Factors contained in this Annual Report on Form 10-K. RESULTS OF OPERATIONS The following discussion and SIZE="2">We develop, manufacture, market and sell orthopaedic implant devices, related surgical instrumentation, supplies and biologic materials to hospitals and physicians in the United States and internationally. Our revenues are derived from Our operating expenses consist of sales and marketing expenses, general and administrative expenses, research and In marketing our products, we use a combination of traditional targeted media marketing together with our primary marketing | EXCERPTS ON THIS PAGE:
RELATED TOPICS for EXAC: |
| |||||||